RayzeBio Common Stock Statistics Share Statistics RayzeBio Common Stock has 60.02M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 60.02M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 34.82M Failed to Deliver (FTD) Shares 69,419 FTD / Avg. Volume 9.31%
Short Selling Information The latest short interest is 847.93K, so 1.41% of the outstanding
shares have been sold short.
Short Interest 847.93K Short % of Shares Out 1.41% Short % of Float 1.48% Short Ratio (days to cover) 2.86
Valuation Ratios The PE ratio is -13.72 and the forward
PE ratio is null.
RayzeBio Common Stock's PEG ratio is
-0.1.
PE Ratio -13.72 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio -8.46 P/FCF Ratio -15.49 PEG Ratio -0.1
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for RayzeBio Common Stock.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 28.69,
with a Debt / Equity ratio of -0.09.
Current Ratio 28.69 Quick Ratio 28.69 Debt / Equity -0.09 Debt / EBITDA -0.15 Debt / FCF -0.17 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-779.55K Employee Count 88 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 3.79, so RayzeBio Common Stock's
price volatility has been higher than the market average.
Beta 3.79 52-Week Price Change n/a 50-Day Moving Average 61.51 200-Day Moving Average n/a Relative Strength Index (RSI) 88.25 Average Volume (20 Days) 745,490
Income Statement
Revenue n/a Gross Profit n/a Operating Income -72.12M Net Income -68.6M EBITDA -70.59M EBIT -72.12M Earnings Per Share (EPS) -1.75
Full Income Statement Balance Sheet The company has 129.16M in cash and 10.57M in
debt, giving a net cash position of 118.59M.
Cash & Cash Equivalents 129.16M Total Debt 10.57M Net Cash 118.59M Retained Earnings -130.12M Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -51.68M
and capital expenditures -9.1M, giving a free cash flow of -60.78M.
Operating Cash Flow -51.68M Capital Expenditures -9.1M Free Cash Flow -60.78M FCF Per Share -1.55
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
